Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Knost

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Oncogene|June 9, 2009
Frequent loss of cystatin E/M expression implicated in the progression of prostate cancerS M Pulukuri, B Gorantla, J A Knost, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1983
Determination of the optimal human cell lines for development of human hybridomasP G Abrams, J A Knost, G Clarke, et al.
Cancer Treatment Reports|November 1, 1981
Cyclophosphamide, doxorubicin, and cisplatin in the treatment of advanced non-small cell lung cancerJ A Knost, F A Greco, K R Hande, et al.
Journal of Clinical Laboratory Analysis|September 24, 1999
Utility of flow cytometry in subtyping composite and sequential lymphomaJ D Siebert, D A Mulvaney, A M Vukov, et al.
Cancer Treatment Reports|September 1, 1982
Phase II study of vindesine in patients with advanced breast cancerB K Walker, P C Raich, J Fontana, et al.
Cancer Treatment Reports|May 1, 1983
Combination of vindesine and prednisone in malignant lymphoma and acute leukemiaP C Raich, B K Walker, J S Rogers, et al.
American Journal of Clinical Pathology|May 11, 2001
Comparison of lymphoid neoplasm classification. A blinded study between a community and an academic settingJ D Siebert, L A Harvey, P A Fishkin, et al.
Annals of Internal Medicine|May 1, 1983
Recombinant leukocyte A interferon in advanced breast cancer. Results of a phase II efficacy trialS A Sherwin, D Mayer, J J Ochs, et al.
Archives of Pathology & Laboratory Medicine|December 2, 2000
Utility of flow cytometry immunophenotyping for the diagnosis and classification of lymphoma in community hospital clinical needle aspiration/biopsiesJ D Siebert, L M Weeks, L W List, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1983
The treatment of cancer patients with human lymphoblastoid interferon. A comparison of two routes of administrationJ A Knost, S A Sherwin, P G Abrams, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Oncogene|June 9, 2009
Frequent loss of cystatin E/M expression implicated in the progression of prostate cancerS M Pulukuri, B Gorantla, J A Knost, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1983
Determination of the optimal human cell lines for development of human hybridomasP G Abrams, J A Knost, G Clarke, et al.
Cancer Treatment Reports|November 1, 1981
Cyclophosphamide, doxorubicin, and cisplatin in the treatment of advanced non-small cell lung cancerJ A Knost, F A Greco, K R Hande, et al.
Journal of Clinical Laboratory Analysis|September 24, 1999
Utility of flow cytometry in subtyping composite and sequential lymphomaJ D Siebert, D A Mulvaney, A M Vukov, et al.
Cancer Treatment Reports|September 1, 1982
Phase II study of vindesine in patients with advanced breast cancerB K Walker, P C Raich, J Fontana, et al.
Cancer Treatment Reports|May 1, 1983
Combination of vindesine and prednisone in malignant lymphoma and acute leukemiaP C Raich, B K Walker, J S Rogers, et al.
American Journal of Clinical Pathology|May 11, 2001
Comparison of lymphoid neoplasm classification. A blinded study between a community and an academic settingJ D Siebert, L A Harvey, P A Fishkin, et al.
Annals of Internal Medicine|May 1, 1983
Recombinant leukocyte A interferon in advanced breast cancer. Results of a phase II efficacy trialS A Sherwin, D Mayer, J J Ochs, et al.
Archives of Pathology & Laboratory Medicine|December 2, 2000
Utility of flow cytometry immunophenotyping for the diagnosis and classification of lymphoma in community hospital clinical needle aspiration/biopsiesJ D Siebert, L M Weeks, L W List, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1983
The treatment of cancer patients with human lymphoblastoid interferon. A comparison of two routes of administrationJ A Knost, S A Sherwin, P G Abrams, et al.
Pageof 2